Our previous research found the amplification frequency of pyrimidine metabolic pathway related genes in ESCC samples was significantly higher than that in paracancerous samples [8], and thymidylate synthase (TYMS) was one of many abnormal genes. The gene discussed is TYMS; the disease is esophageal squamous cell carcinoma.